double-unit umbilical cord blood transplantation
Sponsors
National Cancer Institute (NCI), Fred Hutchinson Cancer Center, Case Comprehensive Cancer Center, University of Medicine and Dentistry of New Jersey
Conditions
Accelerated Phase Chronic Myelogenous LeukemiaAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Phase 1
Phase 2
Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
CompletedNCT00025038
Start: 2001-06-30Updated: 2013-04-11
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
CompletedNCT00719888
Start: 2005-11-18End: 2024-12-19Updated: 2025-03-07
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
CompletedNCT01093586
Start: 2007-09-30End: 2015-12-31Updated: 2019-01-23
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
WithdrawnNCT01652014
Start: 2014-01-31End: 2017-01-31Updated: 2016-07-14